Avricore Health INC 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink

16 Jun 2025

AVCRF

Avricore Health INC

20-F: Avricore Health Reports Strong Revenue Growth Amid Strategic Shift from Shoppers Drug Mart to UK and Rexall Expansion

Avricore Health Inc. reported a 37% increase in annual revenue for fiscal year 2024, reaching $4.78 million, while navigating a significant strategic pivot away from its major Canadian pharmacy partner, Shoppers Drug Mart, towards new growth opportunities in the UK and with Rexall.

OTC.Pink

12 Jun 2024

AVCRF

Avricore Health INC

20-F: Avricore Health Inc. Reports Increased Revenue and Gross Profit in 2023 Annual Report

Avricore Health Inc.'s 2023 annual report highlights a 97% increase in revenue and a 163% increase in gross profit, driven by the expansion of its HealthTab point-of-care testing platform.